TK
Ted William Karkus
CEO & ChairmanDirector

Ted William Karkus insider trades: ProPhase Labs (PRPH) stock buys and sales

CEO & Chairman, ProPhase Labs Last trade Jun 3, 2021 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2011
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ted reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 3, 2021PRPH↑ Buy$172K
Aug 13, 2020PRPH↓ Sell$138K
Mar 26, 2020PRPH↓ Sell$175K
Dec 21, 2017PRPH↓ Sell$977K
Sep 29, 2017PRPH↓ Sell$839K
Jun 4, 2015PRPH↑ Buy$260K
May 19, 2015PRPH↑ Buy$283K
Jun 25, 2013PRPH↑ Buy$780K
May 17, 2012PRPH↑ Buy$247K
Nov 16, 2011PRPH↑ Buy$17K
Nov 14, 2011PRPH↑ Buy$146K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ted William Karkus's insider trades

Ted William Karkus is CEO & Chairman at ProPhase Labs (PRPH). Since Nov 14, 2011, Ted has reported 7 open-market purchases worth $1.9M and 4 sales worth $2.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), option exercises (7 filings), shares withheld for taxes (6 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.